2016
DOI: 10.1016/j.ctrv.2016.07.001
|View full text |Cite
|
Sign up to set email alerts
|

The cancer stem-cell signaling network and resistance to therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
118
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 126 publications
(123 citation statements)
references
References 96 publications
4
118
0
Order By: Relevance
“…This is consistent with other works describing that PIM phosphorylates and enhances OCT4 and MYC, which also contributes to the reprogramming of tumor cells852. Furthermore, other PIM-dependent pathways promoting the self-renewal of stem cells have been reported53545556. PIM kinases might influence self-renewal and reprogramming through direct phosphorylation of BCRP/ABCG2, a putative stem cell marker, which may be involved in multiple drug resistance57.…”
Section: Discussionsupporting
confidence: 91%
“…This is consistent with other works describing that PIM phosphorylates and enhances OCT4 and MYC, which also contributes to the reprogramming of tumor cells852. Furthermore, other PIM-dependent pathways promoting the self-renewal of stem cells have been reported53545556. PIM kinases might influence self-renewal and reprogramming through direct phosphorylation of BCRP/ABCG2, a putative stem cell marker, which may be involved in multiple drug resistance57.…”
Section: Discussionsupporting
confidence: 91%
“…506,507 IL-1 stimulates the secretion of PGE2 via autocrine signaling, which ultimately activates β-catenin signaling in cancer cells in a paracrine manner and transforms cancer cells into CSCs. 508 In the ECM, bone mesenchymal stem cells activate the NF-κB pathway and induce a CSC phenotype by secreting a variety of cytokines and chemokines, such as CXCL12, CXCL7, and IL-6/IL-8. 509 The interaction between MDSCs and CSCs via IL-6/STAT3 and Notch signaling is critical to the progression of breast cancer.…”
Section: Major Signaling Pathways In Cscsmentioning
confidence: 99%
“…Moreover, parthenolide was the first small molecule shown to selectively kill cancer stem cells, while leaving normal stem cells intact [524,534]. This is of enormous therapeutic importance, since the presence of cancer stem cells is considered as one of the main reasons underlying chemotherapy resistance and tumor relapse due to their capacity of self-renewal and differentiation into multiple cell types [535,536]. The mechanism behind parthenolide selectivity towards cancer stem cells is not completely understood, but it is believed that the reason lies in its ability to target multiple major pathways required for cancer stem cell survival and self-renewal, such as MAPK, JAK/STAT, PI3K and NF-κB signaling [524,537].…”
Section: Targeting Chromosome Congression For Cancer Therapymentioning
confidence: 99%